Virtual Incision Names Intuitive Veteran Jim Alecxih as CEO

Virtual Incision has appointed Jim Alecxih as its new chief executive officer (CEO).

Alecxih brings over three decades of experience transforming surgical technologies. This includes a tenure at Intuitive Surgical where he was key in the da Vinci surgical system’s adoption and growth.

He was previously CEO of DH Medical an artificial intelligence (AI) software company. Alecxih also served in executive leadership roles in multiple healthcare startups and growth-stage companies. At Intuitive, he led U.S. sales and helped drive adoption of robotic-assisted surgery at hospitals and health systems across the world.

Virtual Incision is currently preparing for accelerated development and commercialization of its next-gen M2 system, planning for a series of submissions in various specialties to the U.S. Food and Drug Administration (FDA). M2 is a miniaturized, single-port surgical robotic system that was engineered to be smart, simple, and small.

RELATED: Virtual Incision’s MIRA Robot Completes 1st Hysterectomy

It could potentially minimize cost and complexity of current mainframe cart-based surgical robotic systems. The company said M2 will by optimized to deliver robotic-assisted surgery to hospitals and surgical settings without access to surgical robotic technologies.

“The opportunity to lead Virtual Incision at this pivotal time is an extraordinary honor,” said Alecxih. “I believe deeply in the benefits of robotic-assisted surgery to both patients, surgeons and hospitals. M2 has the potential to dramatically expand access to robotic-assisted surgery in rural hospitals, HOPD and ASC settings, and around the world. Virtual Incision’s visionary approach is to ensure that robotic-assisted surgery is more accessible, flexible and scalable for a broader range of operating environments. I’m thrilled to join this talented team and help accelerate our impact on patients and providers.”

The company’s MIRA system was designed as a portable, scalable solution for minimally invasive procedures with a small footprint and simple setup. The device—which earned FDA de novo authorization last year—weights about two pounds and offers internal triangulation with shoulders, arms, and infinite wrist roll inside of the body. It can be used in any operating room, the company said.